Hepatitis B (HBV) vaccines
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
VACCINE TYPE
- Hepilsav-B: yeast-derived vaccine created with a novel adjuvant Toll-like receptor 9 (TLR9) agonist adjuvant
- Recombivax HB: recombinant vaccine produced by Saccharomyces cerevisiae (baker’s yeast).
- Engerix-B: recombinant vaccine, also produced by Saccharomyces cerevisiae.
- Twinrix: bivalent vaccine providing protection against both hepatitis A and B: HAV (720 ELISA units/mL) and HBV (20mcg HBsAg/mL).
- Comvax: bivalent vaccine providing protection against both Haemophilus influenzae type b and hepatitis B virus (no longer available in the U.S.)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
VACCINE TYPE
- Hepilsav-B: yeast-derived vaccine created with a novel adjuvant Toll-like receptor 9 (TLR9) agonist adjuvant
- Recombivax HB: recombinant vaccine produced by Saccharomyces cerevisiae (baker’s yeast).
- Engerix-B: recombinant vaccine, also produced by Saccharomyces cerevisiae.
- Twinrix: bivalent vaccine providing protection against both hepatitis A and B: HAV (720 ELISA units/mL) and HBV (20mcg HBsAg/mL).
- Comvax: bivalent vaccine providing protection against both Haemophilus influenzae type b and hepatitis B virus (no longer available in the U.S.)
There's more to see -- the rest of this entry is available only to subscribers.